Figure 1.
Dynamics of respiratory function parameters in breast cancer patients during the intervention
| Indicator Beginning | Group A (n=34) | p Beginning | Group B (n=34) | p | |||
|---|---|---|---|---|---|---|---|
| 12-week | 12-week | ||||||
| Vital capacity, l | Actual | 2.38±0,06 | 2.81±0.04** | <0.001 | 2.41±0.04 | 2.54±0.05 | >0.05 |
| % of predicted | 76.03±2.52 | 89.50±1.82** | <0.001 | 75.93±1.54 | 80.00±2.11 | >0.05 | |
| Forced vital capacity, l | Actual | 2.36±0.06 | 2.67±0.04** | <0.001 | 2.40±0.06 | 2.48±0.04 | >0.05 |
| % of predicted | 79.97±2.85 | 90.20±1.99** | <0.001 | 79.97±2.08 | 82.57±1.94 | >0.05 | |
| Forced expiratory volume in 1 second, 1 | Actual | 1.93±0.08 | 2.23±0.05 | <0.01 | 1.92±0.05 | 2.22±0.03 | <0.001 |
| % of predicted | 79.63±4.27 | 91.37±2.46 | <0.01 | 76.93±2.18 | 89.27±1.93 | <0.001 | |
| Respiratory minute volume, l/min | 7.17±0.60 | 6.95±0.29 | >0.05 | 7.51±0.34 | 8.01±0.53 | >0.05 | |
| Maximal voluntary ventilation, l/min | 70.94±4.42 | 85.36±4.52** | <0.01 | 66.24±4.17 | 67.88±4.02 | >0.05 | |
| Expiratory reserve volume, l | 1.01±0.10 | 1.26±0.06*** | <0.05 | 0.87±0.05 | 0.89±0.05 | >0.05 | |
| Inspiratory reserve volume, l | 1.07±0.10 | 1.17±0.05 | >0.05 | 1.09±0.07 | 1.20±0.06 | >0.05 | |
Demographic and treatment-related characteristics of study participants
| Characteristics | Water exercise group (n=34) | Pilates group (n=34) | P |
|---|---|---|---|
| Age, (M±m) | 57.44±2.16 | 57.99±2.24 | >0.05 |
| Race: | |||
| White, n (%) | 33 (97%) | 32 (94%) | >0.05 |
| Black, n (%) | 1 (3%) | 2 (6%) | >0.05 |
| Married/committed relationship, n (%) | 28 (82%) | 27 (79%) | >0.05 |
| High school graduate, n (%) | 13 (38%) | 12 (35%) | >0.05 |
| College graduate, n (%) | 19 (56%) | 20 (59%) | >0.05 |
| Post-graduate, n (%) | 2 (6%) | 2 (6%) | >0.05 |
| Body mass index, kg/m2, (M±m) | 25.92±0.42 | 26.01±0.81 | >0.05 |
| Treatment: | |||
| Surgery type (mastectomy by Madden), n (%) | 34 (100%) | 34 (100%) | >0.05 |
| Adjuvant therapy: | |||
| Radiotherapy | 30 (88%) | 31 (91%) | >0.05 |
| Chemotherapy | 4 (12%) | 3 (9%) | >0.05 |
| Time after surgery, months | 5.23±0.32 | 5.11±0.42 | >0.05 |
| Cancer Stage: | |||
| Stage 1, n (%) | 12 (35%) | 13 (38%) | >0.05 |
| Stage 2, n (%) | 22 (65%) | 21 (62%) | >0.05 |
| Degree of lymphedema: | |||
| I-st degree, n (%) | 5 (15%) | 6 (17%) | >0.05 |
| II-nd degree, n (%) | 19 (56%) | 19 (56%) | >0.05 |
| III-rd degree, n (%) | 10 (29%) | 9 (27%) | >0.05 |